Participant responses to the round 1 questionnaire: Responses are based on an 11-point scale (0 = unimportant and 10 = essential).
| ITEM | AVERAGE IMPORTANCE SCORE |
|---|---|
| Patient background information | |
| • Genotype | 10.0 |
| • Contraindication to treatment | 9.1 |
| • Specialist name | 6.3 |
| • Biopsy findings | 7.7 |
| • Ultrasound findings | 7.1 |
| Counseling | |
| • Alcohol avoidance | 7.2 |
| • Cigarette avoidance | 5.6 |
| • Marijuana avoidance | 4.8 |
| • Acetaminophen avoidance | 4.2 |
| • NSAID avoidance | 6.7 |
| • Weight loss | 4.4 |
| • Safe-sex practices | 6.8 |
| • Avoidance of needle sharing | 8.7 |
| • Hepatitis A vaccine | 8.0 |
| • Hepatitis B vaccine | 8.7 |
| Biochemical monitoring | |
| • AST | 7.5 |
| • ALT | 7.5 |
| • Platelet | 7.7 |
| • AFP | 2.1 |
| • HCV RNA | 9.4 |
| • MELD score | 5.8 |
| • Ultrasound | 8.7 |
| • CT scan | 1.5 |
| • Liver biopsy | 5.3 |
| • HIV | 9.1 |
AFP—α-fetoprotein, ALT—alanine aminotransferase, AST—aspartate aminotransferase, CT—computed tomography, HCV—hepatitis C virus, MELD—model for end-stage liver disease, NSAID—nonsteroidal anti-inflammatory drug.